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Abstract The prevalence of tuberculosis (TB) continues to
rise worldwide. Current migration patterns and increased
travel to high-prevalence TB countries will result in more
frequent presentations of less common forms of TB.
Tuberculous dactylitis, a form of tuberculous osteomyelitis,
is well recognised in countries with a high prevalence of
TB. We provide a systematic review of all published cases
of tuberculous dactylitis in children and adolescents and
describe a case to illustrate the typical features of the
disease. Our review revealed 37 cases of tuberculous
dactylitis in children and adolescents, all reported in the
last 17 years. Children less than 10 years of age are most
frequently affected and the hand is the most commonly
affected site. Concurrent pulmonary TB is present in a fifth
of cases and systemic symptoms are usually absent.
Positive TST and IGRA support the presumptive
diagnosis, but cannot be used as rule-out tests. The
definitive diagnosis relies on the detection M. tuberculosis
by PCR or culture. Treatment should comprise of a
standard three to four drug anti-tuberculous regimen. The
optimal treatment duration remains unknown. Surgery has a
limited role in the treatment in general but may play a
supportive role, and curettage of the cavity has been
recommended for avascular lesions.
Introduction
The prevalence of tuberculosis (TB) continues to rise
worldwide [1]. With increasing migration from regions
with a high prevalence of TB and increasing numbers of
travellers to high-prevalence TB countries [2], less common
forms of TB will be seen more frequently in industrialised
countries. Extrapulmonary TB is more common in children
and adolescents than adults, accounting for approximately
one quarter of paediatric cases [3]. Less common forms of
TB, such as tuberculous dactylitis, are well recognised in
countries with a high prevalence of TB but may prove a
diagnostic challenge to clinicians in industrialised countries
who may be unfamiliar with the clinical features. This
review summarises the epidemiology, clinical features and
management of tuberculous dactylitis. It includes an
illustrative case that highlights the important features as
well as a summary of all previously published cases in
children and adolescents.
Illustrative case
A 15-year-old Australian-born girl of Cambodian descent
presented with a 6-month history of a swollen right middle
finger associated with mild pain (Fig. 1, panel A). She did
not recall any trauma and was otherwise well. She had not
experienced similar symptoms in the past and there was no
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family history of rheumatological diseases. Her immunisa-
tions were up-to-date according to Australian guidelines,
which do not routinely include Bacille Calmette-Guérin
(BCG) vaccine. She had lived in Cambodia for one year at
the age of 18 months. She had also visited Cambodia for a
five-week period when she was 10 years old. At presenta-
tion, the only abnormal physical finding was swelling of the
proximal phalanx of the right middle finger without
associated erythema or tenderness. Inflammatory markers
including white blood cell count, C-reactive protein and
erythrocyte sedimentation rate were within the normal
range. Serology for human immunodeficiency virus was
negative. Radiography showed a diffuse abnormality in the
proximal phalanx of the right middle finger with a mottled
appearance (Fig. 1, panel b). A tuberculin skin test (TST)
showed 22 mm induration after 72 hours. An interferon
gamma release assay (IGRA) (QuantiFERON-TB Gold In
Tube, Cellestis, Australia) was negative. Her chest radiograph
was normal and a radionuclide bone scan did not reveal
involvement of further sites elsewhere.
The medullary cavity of the affected bone was surgically
curetted and lavaged. Histopathology examination of the
bone showed granulomatous inflammation (Fig. 2). Myco-
bacterium tuberculosis was detected in the biopsy specimen
by polymerase chain reaction (PCR) and subsequently by
culture. Treatment was started with isoniazid 300 mg daily,
rifampicin 600 mg daily and pyrazinamide 1000 mg daily
in divided doses. Susceptibility testing of the isolate
revealed a fully sensitive strain and pyrazinamide was
stopped after the initial two months of treatment. Radiog-
raphy after four months of treatment showed improvement
of the honeycomb lesions. Following a total treatment
duration of 9 months, the patient remained well and the
swelling had almost totally resolved. Radiography at the
end of treatment showed resolution of the honeycomb
lesions with healing accompanied by sclerosis (Fig. 1,
Panels c and d).
Search strategy
Publications were identified by a systematic search of
Medline (1950–2010), EMBASE (1950–2010) and Web of
Science (1898–2010) using the following search strategy:
(“dactylitis” OR “ventosa”) AND (“tuberc*” or “TB”).
Reference lists from relevant publications and Google
scholar identified an additional two articles. Publications
in English, French, Italian and German were reviewed. Of
the 114 publications identified, 49 were excluded (46 were
not relevant, three were in other languages [Czech,
Bulgarian and Mandarin]) leaving a total of 65 articles that
were reviewed in detail. Of these, 28 included reports of
tuberculous dactylitis in children and adolescents.
Epidemiology and clinical characteristics
TB osteomyelitis accounts for 1–2% of all TB cases but up
to 10–20% percent of cases of extrapulmonary TB disease
[4, 5]. Spinal TB (Pott’s disease) is the most common form
of tuberculous osteomyelitis. Extraspinal tuberculous oste-
omyelitis may manifest in any location but most commonly
Fig. 1 a Swelling of the right
middle finger with residual scar
following bone biopsy four
weeks prior. b–d Radiograph of
the right middle finger showing
diffuse lytic lesions in the
proximal phalanx (b) before
treatment and progressive
resolution of the lesions with
accompanying sclerosis after
4 months (c) and 9 months
(d) of treatment
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involves the hands, feet, ribs and the skull [4, 6].
Tuberculous dactylitis is a less common but important form
of tuberculous osteomyelitis. Our literature search identified
a total of 37 cases of paediatric tuberculous dactylitis in 28
publications (Table 1). Tuberculous dactytlitis has most
commonly been reported in children less than 10 years of
age (Figs. 2 and 3). The hand is most frequently affected
and only five (14%) out of 37 cases reported in the
literature described tuberculous dactylitis in the foot [7–10].
Osteomyelitis caused by M. tuberculosis is thought to result
from hematogenous spread during primary infection. The
interval between primary infection and onset of symptoms
is difficult to establish as the timing of primary infection is
usually unknown. The index case has only rarely been
identified and our case illustrates also the potential risk of
this form of TB being acquired during travel to high TB
prevalence countries [11]. Concurrent pulmonary TB is
present in about a fifth of reported cases and systemic
symptoms such as fever, night sweats and weight loss are
frequently absent (Table 1). Concomitant involvement of
other sites is present in about a quarter of published cases.
The swelling is usually painless or only mildly painful, which
can be an important feature to distinguish tuberculous from
other causes of dactylitis [12, 13]. It typically affects the
proximal phalanges or the metacarpal bones, most commonly
involving a single bone (Table 1).
Diagnosis
ATST result was reported in 24 (66%) of the 37 cases and was
positive in 21 (88%) and negative in three (12%) [10, 14, 15].
A positive TST therefore may be helpful in supporting the
presumptive diagnosis of tuberculous dactylitis. An IGRA
was not reported in any of the 37 cases previously reported.
Notably, in our illustrative case the IGRAwas negative. Only
a few studies have assessed the performance of IGRAs for
the diagnosis of extrapulmonary TB and in particular for
tuberculous osteomyelitis. Two studies in adults with
tuberculous osteomyelitis suggest a sensitivity of 41–67%
[16, 17]. In addition, the sensitivity of IGRAs in children,
particularly those under 5 years of age has been questioned
[18, 19]. Based on this and the result in our case, an IGRA
should not be used to exclude the diagnosis of tuberculous
dactylitis. Radiographs typically show enlargement of the
bone with periosteal thickening and destruction of the
spongiosa resulting in a cystic appearance called ‘spina
ventosa’. A diffuse infiltration with a lytic honeycomb
appearance, as seen in our case, is less frequent. However,
radiological features are not pathognomonic and confirmation
of the diagnosis requires detection of M. tuberculosis from a
bone biopsy by PCR or culture. Culture from a fine needle
aspiration or from fluid collected from a sinus has also been
shown to be helpful for diagnosis [20–24]. Differential
diagnoses of tuberculous dactylitis include syphilis, acute
bacterial or fungal osteomyelitis, sarcoidosis, gout, sickle
cell dactylitis, bone tumours and rheumatoid arthritis.
Treatment and follow-up
Standard empiric treatment for tuberculous dactylitis is
similar to that for pulmonary TB, comprising a three to four
drug regimen including isoniazid, rifampicin, pyrazinamide
and ethambutol. In cases of culture-proven tuberculous
dactylitis with a resistant M. tuberculosis strain, change of
anti-tuberculous drugs guided by resistance testing is
required. Traditionally, a treatment duration of 12–
Fig. 2 Haematoxylin and eosin stained sections of the bone biopsy
showing granulomatous osteomyelitis typically seen in tuberculous
osteomyelitis. a The 5-fold magnification shows central caseating
necrosis (white arrows) surrounded by granulomatous inflammation
(black arrows); bone fragments are also seen (grey arrow). b The 20-
fold magnification shows a granuloma (black arrows) composed of
lymphocytes and epithelioid histiocytes with an adjacent multinucleate
giant cell (white arrow)
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18 months has been recommended for tuberculous osteo-
myelitis based on concerns about poor bone penetration and
the difficulty of confirming cure [25]. The World Health
Organization recommends a treatment duration of 9 months
for TB osteomyelitis because of the difficulty in assessing
treatment response [26]. A third of the case reports of
tuberculous dactylitis did not detail the choice of anti-
tuberculous drugs or the duration of treatment. Of those that
specified the treatment duration, this was most commonly
9–12 months. The longest treatment duration reported was
18 months and one study did not treat with anti-tuberculous
drugs and suggested “spontaneous complete healing is the
rule” [27]. Prospective studies investigating treatment for
tuberculous osteomyelitis in the spine suggest that a
treatment regimen including isoniazid and rifampicin for a
duration of 6–9 months is effective [28, 29]. It has also
been suggested that 6 months of antituberculous treatment
is sufficient as bacillary load is considered low in
tuberculous dactylitis [9]. However, one recent retrospec-
tive study showed over 60% relapse rate in patients with
spinal tuberculous osteomyelitis treated for six months
compared to 0% relapse rate in those treated for nine
months [30]. It is unclear whether data from spinal
tuberculous osteomyelitis can be extrapolated to the
treatment of tuberculous dactylitis. As evidence for the
optimal treatment duration is not conclusive, we elected to
treat our patient for 9 months. Surgery has a limited role in
the treatment of tuberculous osteomyelitis in general but
does have an important role in complicated spinal tuberculous
osteomyelitis [28, 31]. For tuberculous dactylitis, surgery
may play a supportive role and curettage of the cavity has
been recommended for avascular lesions, for which anti-
tuberculous therapy alone is unlikely to be successful
[10, 25]. Monitoring clinical response for tuberculous
dactylitis is difficult. C-reactive protein and erythrocyte
sedimentation rate are frequently not elevated and repeat
culture of the affected area is not practical. Clinical improve-
Fig. 3 Age distribution of published cases of tuberculous dactylitis in
children and adolescents
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ment together with repeat imaging is therefore most com-
monly advocated for monitoring treatment success [10, 25].
Prevention
It is likely that the BCG immunisation that infants in high-
risk TB countries receive routinely at birth plays an
important role in preventing all forms of TB including
dactylitis [32]. However, no study has investigated the
protective efficacy of BCG specifically for tuberculous
dactylitis. It is notable that the patient described in our
illustrative case was not BCG immunised.
Conclusion
Tuberculous dactylitis is a readily-treatable disease that is
easily missed. It needs to be considered even in the absence of
pulmonary and constitutional symptoms or when potential
exposure toM. tuberculosis has occurred many years earlier.
Positive TST and IGRA may support the presumptive
diagnosis, but cannot be used as rule-out tests. The definitive
diagnosis relies on the detection of M. tuberculosis by PCR
or culture from a bone biopsy, or fluid from a fine needle
aspiration or draining sinus. Unless susceptibility testing
reveals resistance, treatment should comprise a standard
three to four drug anti-tuberculous regimen for 2 months
followed by treatment with isoniazid and rifampicin for the
remaining treatment duration. The optimal treatment duration
remains unknown but current data does not support treatment
longer than 12 months and most reported cases suggest
9 months of treatment is sufficient.
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